In an attempt to define the pancreatic B cell function in the elderly, we subjected 88 non-obese individuals (aged between 21 and 88) to an oral glucose tolerance test (OGTT), a simple glucagon test (SGT) and OGTT-glucagon test, in which the plasma glucose, insulin and serum C-peptide (CPR) were measured. We investigated heterogeneity in glucose intolerance in the elderly and its relationship to atherosclerosis.
In the OGTT and SGT test, the insulin responses (SIRI/SPG ratios) for normal, borderline and DM, (fasting plasma glucose<140 mg/dl and 2 h-PG≥200 mg/dl) groups of the elderly (60 and above) were not significantly different from those for normal group of young and middle-aged (below 60) and were significantly higher for elderly group than for the young and middle-aged group in each glucose tolerance group. But the insulin responses for the DM
2 (fasting plasma glucose≥140 mg/dl and 2 h-PG≥200 mg/dl) group of the elderly were not significantly different from those for the DM
1 and DM
2 groups of young and middle-aged.
The insulin responses of normal, borderline and DM
4 groups of the elderly with atherosclerosis were significantly higher than those of the comparable groups without atherosclerosis, while the insulin responses of the borderline and DM
1 groups of the elderly with atherosclerosis were similar to those of the control group of the young.
In the OGTT-glucagon test, there were no differences in the insulin response or serum CPR response among the normal, borderline and DM
1 groups of the elderly, and these responses were significantly higher for the elderly group than the for young and middle-aged group in each glucose tolerance group. But these responses for the DM
2 group of the elderly were not significantly different from those for the DM
1 and DM
2 groups of the young and middle-aged.
These results indicate that the pancreatic B cell function of the normal group in the elderly remains favorable while mildly impaired glucose tolerance was exhibited by the borderline and DM
1 groups, who are comparable with the normal group of the young and middle-aged. But this function was clearly reduced in the DM
2 group of the elderly.
These findings suggest that there is a subgroup in the elderly, which has clinically evident atherosclerosis, mild glucose intolerance and high insulin response. Their pancreatic B cell function remains favorable.
View full abstract